Savings Under Most-Favored-Nation Pricing for Prescription Drugs in Medicaid

This study compares current Medicaid rebates with international reference prices and estimated potential savings under the Generating Cost Reductions for US Medicaid payment model.

Corresponding Author: Thomas J. Hwang, MD, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, 41 Avenue Louis Pasteur, Boston, MA 02115 (tjhwang@post.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.